Edward Jones has upgraded CVS Health (NYSE:CVS) to buy from hold, citing a potential turnaround in its Aetna insurance ...

CVS Health’s new chief executive, David Joyner, moved quickly to put his stamp on the company, promising a reorganization and ...

CVS Health plans to eliminate another 22 jobs connected to its offices in Hartford, 10 of which are held by Connecticut ...

CVS Health (NYSE: CVS) is a big name in healthcare, and it has generally been seen as a good way to invest in the industry.

Edward Jones has upgraded CVS Health (NYSE:CVS) to buy from hold, citing a potential turnaround in its Aetna insurance business. The investment firm said it believes CVS (NYSE:CVS) will improve ...

Paul Kusserow, CEO of home health care provider Amedysis and a former Humana executive, thinks CVS Health's agreement to buy Aetna, announced on Monday, is "very exciting." ...

Edward Jones last night upgraded CVS Health (CVS) to Buy from Hold. The company could be an attractive turnaround story” with the potential for ...

Benchmark upgraded Meta Platforms (META) to Buy from Hold with a $820 price target, citing a "strong" 2025 core business ...

With its acquisition of Aetna in 2018, it has also become a key ... strategy could be key in determining if CVS stock is a good buy CVS' new CEO David Joyner took over in October, which means ...

Aetna alleges generic drugmakers colluded to ... losses and prevent future anticompetitive practices. Price Action: CVS stock is up 2.31% at $46.85 at last check Monday.

In another report released yesterday, Truist Financial also maintained a Buy rating on the ... a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance ...